Abstract
With the advancement of neonatal care and routine blood pressure monitoring, neonatal hypertension (NHT) has been increasingly recognised over the past few decades. NHT is known to cause target organ damage and risk of renal dysfunction later in life. However, diagnosis and management of NHT remain challenging, and there is a lack of evidence on the persistence of hypertension beyond the neonatal period and factors predicting its severity. This study aimed to identify risk factors, clinical profiles, predictors of the severity of hypertension, and short-term outcomes of NHT. A cohort of neonates diagnosed with hypertension requiring pharmacotherapy from September 2019 to July 2021 was prospectively enrolled. Demographic data, risk factors, the severity of hypertension, target organ damage, and follow-up for the persistence of hypertension at 3, 6, and 12 months of age were recorded. Of 1682 neonates admitted during this period, 34 had hypertension requiring pharmacotherapy, with a hospital incidence rate of 2%. Of these, 19 (55.9%) were preterm, 14 (41.2%) very low birth weight, and 15 (44.1%) were small for gestational age. Malignant hypertension was seen in 29 (85%) cases, moderate hypertension in 5 (15%) cases, and target organ damage (heart, brain, liver) was seen in 10 (29.4%) cases. On univariate and multivariate regression, an increasing total number of postnatal risk factors was an independent predictor of the occurrence of hypertensive crisis (OR = 3.5, p = 0.04; 95% CI 1.06–11.42). A significant positive correlation (p = 0.004) was observed between total number of postnatal risk factors and the duration of hospital stay. Renal causes of hypertension were identified significantly earlier (day 14 vs. 23, p = 0.01, 95% CI 2.5–17) and had shorter hospital stay (24 vs 45 days, p = 0.002, 95% CI 834). At 3 months follow-up, 7 (20.6%) babies were still requiring antihypertensive therapy, and 1 (3%) required antihypertensives at 6 and 12 months of age.
Conclusion: NHT is a clinically important but underrecognised entity. Hypertension was seen in preterm, low birth weight neonates and associated with certain maternal and postnatal risk factors, with majority responding to a single drug. Neonates with multiple comorbid illnesses need careful monitoring for hypertension as they are at a higher risk of developing hypertensive crisis. Most NHT cases were normotensive at the time of discharge and did not require pharmacotherapy beyond the neonatal period.
What is Known: • Neonatal hypertension (NHT) is an under-recognised entity, and the spectrum of clinical presentation varies from asymptomatic to severe target organ damage. • Hypertension is commonly seen in preterm, low birth weight neonates and associated with certain maternal and postnatal risk factor. | |
What is New: • NHT is mostly transient, but intrauterine growth retardation, use of antenatal steroids, renal dysfunction due to congenital anomalies, drugs, and chronic lung disease may lead to the persistence of hypertension beyond the neonatal period. • Neonates with multiple comorbid illnesses need careful monitoring for hypertension as they are at a higher risk of developing hypertensive crisis. Three-fourths of hypertensive neonates respond to a single antihypertensive drug, and only one-fourth of patients required an additional drug to control hypertension. Most neonates respond to short duration of treatment, and only a few patients require long-term therapy. |
Similar content being viewed by others
Data availability
Data is not publicly accessible but can be provided on request with prior permission from institute.
Abbreviations
- BP:
-
Blood pressure
- HELLP:
-
Hemolysis, elevated liver enzymes, low platelets
- NHT:
-
Neonatal hypertension
- NICU:
-
Neonatal intensive care unit
References
Adelman RD (1978) Neonatal hypertension. Pediatr Clin North Am 25(1):99–110
Lurbe E, Garcia-Vicent C, Torro I et al (2007) First-year blood pressure increase steepest in low birthweight newborns. J Hypertens 25(1):81–6
AlMaazmi A, Hagan J, Fernandes CJ, Gowda SH (2023) Neonatal systemic hypertension across the PHIS database: An update. Int J Cardiol 376:49–53
Starr MC, Wilson AC (2022) Systemic hypertension in infants with bronchopulmonary dysplasia. Curr Hypertens Rep 24(6):193–203
Kent AL, Chaudhari T (2013) Determinants of neonatal blood pressure. Curr Hypertens Rep 15(5):426–32
Sahu R, Pannu H, Yu R et al (2013) Systemic hypertension requiring treatment in the neonatal intensive care unit. J Pediatr 163(1):84–8
Seliem WA, Falk MC, Shadbolt B, Kent AL (2007) Antenatal and postnatal risk factors for neonatal hypertension and infant follow-up. Pediatr Nephrology 22(12):2081–7
Zubrow AB, Hulman S, Kushner H, Falkner B (1995) Determinants of blood pressure in infants admitted to neonatal intensive care units: a prospective multicenter study. Philadelphia Neonatal Blood Pressure Study Group. Journal of perinatology: Official Journal of the California Perinatal Association 1;15(6):470–9
Dionne JM, Abitbol CL, Flynn JT (2012) Hypertension in infancy: diagnosis, management and outcome. Pediatr Nephrol 27:17–32
Flynn JT, Kaelber DC, Baker-Smith CM et al (2017) Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 1;140(3)
Sharma D, Farahbakhsh N, Shastri S, Sharma P (2017) Neonatal hypertension. J Matern Fetal Neonatal Med 30(5):540–50
Mihai L (2007) Neonatal hypertension--diagnostic and therapeutic approach. Revista Medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 1;111(3):593–600.
Starr MC, Flynn JT (2018) Neonatal hypertension: cases, causes, and clinical approach. Pediatr Nephrol 34(5):787–99
Seliem WA, Falk MC, Shadbolt B, Kent AL (2007) Antenatal and postnatal risk factors for neonatal hypertension and infant follow-up. Pediatric Nephrology 22(12):2081–7
Dionne JM, Flynn JT (2017) Management of severe hypertension in the newborn. Arch Dis Child 102(12):1176–9
Nwankwo MU, Lorenz JM, Gardiner JC (1997) A standard protocol for blood pressure measurement in the newborn. Pediatrics 99(6)
Zappitelli M, Ambalavanan N, Askenazi DJ, Moxey-Mims MM, Kimmel PL, Star RA et al (2017) Developing a neonatal acute kidney injury research definition: a report from the NIDDK neonatal AKI workshop. Pediatr 82(4):569–73
Update on the (1987) Task Force Report on High Blood Pressure in Children and Adolescents: A Working Group Report from the National High Blood Pressure Education Program (1996). Pediatrics 98(4):649–658
Singh HP, Hurley RM, Myers TF (1992) Neonatal hypertension: incidence and risk factors. American journal of hypertension 1;5(2):51–5
Blowey DL, Duda PJ, Stokes P, Hall M (2011) Incidence and treatment of hypertension in the neonatal intensive care unit. J Am Soc 5(6):478–83
Godfrey KM, Barker DJ (2001) Fetal programming and adult health. Public Health Nutr 4(2b):611–24
Fridman AL, Hustead VA (1987) Hypertension in babies following discharge from a neonatal intensive care unit. A 3-year follow-up. Pediatr Nephrol1(1):30–4
Chaudhari T, Falk MC, Jyoti R et al (2013) Neonatal hypertension; a long-term pilot follow-up study. Res Rep Neonatol 3:37–43
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Astha Amrit, Alpana Utture and Kiran More. The first draft of the manuscript was written by Astha Amrit, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethical approval
This is an observational study hence ethical approval was not required.
Informed consent
Written informed consent was obtained from the parents.
Competing interests
The authors declare competing interests.
Additional information
Communicated by Daniele De Luca
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Amrit, A., Utture, A. & More, K. Caring for the hypertensive newborn: a prospective evaluation of risk factors, clinical profile, management, and predictors of outcome of neonatal hypertension. Eur J Pediatr 182, 5367–5374 (2023). https://doi.org/10.1007/s00431-023-05181-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-023-05181-z